Indian billionaires buy foreign companies as growth slows at home
Indian billionaires are increasingly acquiring foreign companies as domestic growth slows. Recent high-profile deals include Sun Pharmaceuticals' $11.75 billion purchase of Organon & Co and Tata Motors' $4.4 billion acquisition of Iveco. Analysts suggest that these acquisitions are driven by strategic needs rather than mere ambition, reflecting a shift in the economic landscape.
- ▪Sun Pharmaceuticals agreed to acquire Organon & Co for $11.75 billion, marking the largest overseas acquisition by an Indian company in nearly two decades.
- ▪162 Indian companies spent over $18 billion on outbound acquisitions in 2025, a 34% increase from the previous year.
- ▪Experts indicate that Indian firms are seeking Western assets for better diversification and operational capabilities.
Opening excerpt (first ~120 words) tap to expand
Indian billionaires buy foreign companies as growth slows at home40 minutes agoShareSaveAdd as preferred on GoogleNikhil InamdarMumbaiBloomberg via Getty ImagesIndia's Sun Pharmaceuticals paid $11.75bn to buy New York-listed Organon & CoIn late April, India's Sun Pharmaceuticals agreed to pay $11.75bn (£8.59bn) to acquire New York-listed women's health and biosimilars firm Organon & Co.It marked the biggest overseas acquisition by an Indian company in nearly two decades and followed a string of high-profile international deals by Indian firms in recent months.These include Tata Motors' $4.4bn acquisition of Turin-based vehicle maker Iveco, IT company Coforge's $2.35bn purchase of Silicon Valley-based AI firm Encora and the Bajaj Group buying a 23% stake in global insurance giant Allianz…
Excerpt limited to ~120 words for fair-use compliance. The full article is at BBC News — Business.
Discussion
0 commentsMore from BBC News — Business
